clofibric acid has been researched along with glyceraldehyde in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balendiran, GK; Haq, W; Martin, HJ; Maser, E; O'Connor, TR; Verma, M | 1 |
Blanchard, JS; Della-Latta, P; Feinmark, SJ; Freeman, S; Kabbash, CA; Kaplan, G; Reich-Slotky, R; Shuman, HA; Silverstein, SC | 1 |
2 other study(ies) available for clofibric acid and glyceraldehyde
Article | Year |
---|---|
Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers.
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzothiazoles; Clofibric Acid; Cysteine; Daunorubicin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyceraldehyde; Humans; Imidazolidines; Kinetics; Mutation; Neoplasms; Oxidation-Reduction; Phthalazines; Pyrimidines; Recombinant Proteins; Serine | 2008 |
Gemfibrozil inhibits Legionella pneumophila and Mycobacterium tuberculosis enoyl coenzyme A reductases and blocks intracellular growth of these bacteria in macrophages.
Topics: Acyl-CoA Dehydrogenases; Amino Acid Sequence; Animals; Cells, Cultured; Clofibric Acid; Enzyme Activation; Escherichia coli; Gemfibrozil; Glyceraldehyde; Humans; Kinetics; Legionella pneumophila; Lipid Metabolism; Macrophages; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Molecular Sequence Data; Mycobacterium tuberculosis; Propane; Sequence Homology, Amino Acid | 2009 |